CN104664223A - Formula food applicable to eating by patients with high blood fat and stroke and preparation method thereof - Google Patents
Formula food applicable to eating by patients with high blood fat and stroke and preparation method thereof Download PDFInfo
- Publication number
- CN104664223A CN104664223A CN201510057381.1A CN201510057381A CN104664223A CN 104664223 A CN104664223 A CN 104664223A CN 201510057381 A CN201510057381 A CN 201510057381A CN 104664223 A CN104664223 A CN 104664223A
- Authority
- CN
- China
- Prior art keywords
- minutes
- blood
- standard
- raw material
- subsequent use
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004369 blood Anatomy 0.000 title claims abstract description 34
- 239000008280 blood Substances 0.000 title claims abstract description 34
- 235000013305 food Nutrition 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims description 9
- 238000002156 mixing Methods 0.000 claims abstract description 22
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 19
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 19
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 19
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 19
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 19
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 19
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 19
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 19
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 19
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 19
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000000835 fiber Substances 0.000 claims abstract description 18
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 18
- 235000010447 xylitol Nutrition 0.000 claims abstract description 18
- 239000000811 xylitol Substances 0.000 claims abstract description 18
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 18
- 229960002675 xylitol Drugs 0.000 claims abstract description 18
- 235000019742 Vitamins premix Nutrition 0.000 claims abstract description 17
- 150000003904 phospholipids Chemical class 0.000 claims abstract description 14
- 241000209140 Triticum Species 0.000 claims abstract description 10
- 235000021307 Triticum Nutrition 0.000 claims abstract description 9
- 238000001035 drying Methods 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims description 30
- 239000000463 material Substances 0.000 claims description 22
- 239000000843 powder Substances 0.000 claims description 21
- 244000046146 Pueraria lobata Species 0.000 claims description 19
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 19
- 230000001769 paralizing effect Effects 0.000 claims description 19
- 241001092040 Crataegus Species 0.000 claims description 18
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 14
- 210000000582 semen Anatomy 0.000 claims description 13
- 239000000284 extract Substances 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 7
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 7
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 7
- 229930003268 Vitamin C Natural products 0.000 claims description 7
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 7
- 238000004140 cleaning Methods 0.000 claims description 7
- 235000019155 vitamin A Nutrition 0.000 claims description 7
- 239000011719 vitamin A Substances 0.000 claims description 7
- 235000019154 vitamin C Nutrition 0.000 claims description 7
- 239000011718 vitamin C Substances 0.000 claims description 7
- 229940045997 vitamin a Drugs 0.000 claims description 7
- 239000012535 impurity Substances 0.000 claims description 6
- 238000010298 pulverizing process Methods 0.000 claims description 4
- 239000005913 Maltodextrin Substances 0.000 claims description 3
- 229920002774 Maltodextrin Polymers 0.000 claims description 3
- 229940035034 maltodextrin Drugs 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 239000008213 purified water Substances 0.000 claims description 3
- 238000001694 spray drying Methods 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 2
- 238000007789 sealing Methods 0.000 claims description 2
- 235000007319 Avena orientalis Nutrition 0.000 abstract description 20
- 235000007558 Avena sp Nutrition 0.000 abstract description 20
- 230000000694 effects Effects 0.000 abstract description 12
- 210000004204 blood vessel Anatomy 0.000 abstract description 10
- 208000024891 symptom Diseases 0.000 abstract description 10
- 208000006011 Stroke Diseases 0.000 abstract description 7
- 230000035699 permeability Effects 0.000 abstract description 5
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 238000007670 refining Methods 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 244000075850 Avena orientalis Species 0.000 description 19
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 10
- 235000013325 dietary fiber Nutrition 0.000 description 6
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 6
- 241000186000 Bifidobacterium Species 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 210000001367 artery Anatomy 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 230000002792 vascular Effects 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 3
- 206010022998 Irritability Diseases 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- 229930003471 Vitamin B2 Natural products 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000008021 deposition Effects 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000001079 digestive effect Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000000050 nutritive effect Effects 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 3
- 229960002477 riboflavin Drugs 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 235000019164 vitamin B2 Nutrition 0.000 description 3
- 239000011716 vitamin B2 Substances 0.000 description 3
- 235000019158 vitamin B6 Nutrition 0.000 description 3
- 239000011726 vitamin B6 Substances 0.000 description 3
- 229940011671 vitamin b6 Drugs 0.000 description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 210000003038 endothelium Anatomy 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- -1 hydroxymethyl glutaryl Chemical group 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 241000209761 Avena Species 0.000 description 1
- 235000005781 Avena Nutrition 0.000 description 1
- 235000007320 Avena fatua Nutrition 0.000 description 1
- 241001647031 Avena sterilis Species 0.000 description 1
- 235000004535 Avena sterilis Nutrition 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 241000209202 Bromus secalinus Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010049976 Impatience Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010022562 Intermittent claudication Diseases 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000005764 Peripheral Arterial Disease Diseases 0.000 description 1
- 208000030831 Peripheral arterial occlusive disease Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 206010047163 Vasospasm Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 206010048214 Xanthoma Diseases 0.000 description 1
- 206010048215 Xanthomatosis Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000170 anti-cariogenic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 210000000133 brain stem Anatomy 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000001013 cariogenic effect Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000004098 cellular respiration Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 239000002384 drinking water standard Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000002641 glycemic effect Effects 0.000 description 1
- 235000020717 hawthorn extract Nutrition 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 235000019680 high-energy food Nutrition 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 208000021156 intermittent vascular claudication Diseases 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 210000001589 microsome Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 210000000633 nuclear envelope Anatomy 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 210000002706 plastid Anatomy 0.000 description 1
- BITYAPCSNKJESK-UHFFFAOYSA-N potassiosodium Chemical compound [Na].[K] BITYAPCSNKJESK-UHFFFAOYSA-N 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000001533 respiratory mucosa Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000001839 systemic circulation Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a formula food applicable to eating by patients with high blood fat and stroke. The formula food is prepared by the following steps: adopting wheat fiber, powdery phospholipid, hawthorn, oat, xylitol, isomaltooligosacharide, radix puerariae and vitamin premix, refining, concentrating, drying, mixing and the like. The formula food has no toxic and side effects; and after the patient eats the formula food, the effects of softening the blood vessels and improving the toughness and the permeability of the blood vessel walls are achieved, so that the purposes of reducing fat and relieving the stroke symptom are achieved.
Description
Technical field
The present invention relates to food, be specifically related to a kind of formula food being applicable to high fat of blood and paralytic and eating, the invention still further relates to the preparation method of this food.
Background technology
Systemic atherosclerosis is accelerated in the direct infringement of high fat of blood, because the vitals of whole body all will rely on artery blood supply, oxygen supply, once artery is blocked by atheromatous plaque, will cause serious consequence even apoplexy.The renal failure etc. that artery sclerosis causes, all closely related with hyperlipemia.
A large amount of medical research shows: the methods for the treatment of of high fat of blood can not only by drug-layer side, and will carry out supplementing to nutrient targetedly and strengthen, with this alleviate that high fat of blood brings have a dizzy spell, have a headache, uncomfortable in chest, breathe hard, have palpitation, pectoralgia, weak, distortion of commissure, the symptom such as mute, extremity numbness, prevent from finally causing the serious disease such as coronary heart disease, headstroke.Long-term blood fat height patient, the atherosclerotic of lipid caused by blood vessel endothelium deposition, can cause coronary heart disease and peripheral arterial disease etc., show as angina pectoris, myocardial infarction, cerebral apoplexy and Charcot's syndrome (after limb activity pain).For now, most of high fat of blood and paralytic still rely on medicine to carry out the balance of stable blood vessel lactones fat, but a large amount of take fat-reducing medicament and can cause a certain amount of damage to liver, can bring out liver diseases for a long time.High fat of blood is angiocardiopathy, one of Major Risk Factors of cranial vascular disease.General first-selected dietary therapy, dietotherapy does not more just adopt drug therapy, and nonetheless, also should not abandon diet control, dietotherapy can improve medication effect.So pass through the strengthening of specific nutrient and supplement, softening blood vessel, improves vascular wall toughness and permeability, just likely reaches the object of safe lipopenicillinase.
Summary of the invention
Technical problem to be solved by this invention is to provide a kind of formula food being applicable to high fat of blood and paralytic and eating, this food of edible for patients, can softening blood vessel, improves vascular wall toughness and permeability, thus reaches lipopenicillinase, alleviates the object of stroke symptom.
For solving the problems of the technologies described above, the technical solution used in the present invention is: a kind of formula food being applicable to high fat of blood and paralytic and eating, and is made up of following raw material:
Semen Tritici aestivi fiber 50%-65%, powdered phospholipid 10%-20%, hawthorn 5%-15%, oat 2%-8%, xylitol 2%-8%, oligoisomaltose 2%-8%, the root of kudzu vine 1%-3%, vitamin premix 0.1%-0.5%.
Wherein, described vitamin premix is that in every 100g vitamin premix, vitamin C contains 195.5mg, Cobastab
1containing 2mg, Cobastab
2containing 2mg, Cobastab
6containing 2mg, vitamin A is containing 0.5mg, and surplus is maltodextrin.
Described Semen Tritici aestivi fiber is wheat after dried, crushed.
Described hawthorn is haw thorn extract, be extract through poach, concentrated, drying and crushing obtains.
Described oat is oat after dried, crushed.
The described root of kudzu vine is kudzu root extract, be extract through poach, concentrated, drying and crushing obtains.
The present invention is applicable to the formula food that high fat of blood and paralytic eat, and its preparation method step is:
(1). the impurity in hawthorn, the root of kudzu vine, foreign matter and the raw material that do not meet quality standard are carried out picking picking cleaning, the purified water adding material quantity 10 times in raw material after cleaning soaks 30 minutes, soaked raw material decocts 1 hour at the temperature of 100 DEG C, extract 2 hours at 100 DEG C of temperature, again temperature 80 DEG C, concentrate 2 hours under pressure-0.08Mpa, carry out centrifugal spray drying to during relative density 1.1, seal up for safekeeping for subsequent use in dried material charging feedstock bucket;
(2). the impurity in wheat, oat, foreign matter and the raw material that do not meet quality standard are carried out picking picking, then at the temperature of 110 DEG C dry 30 minutes, lower the temperature again after drying, finally, dried wheat, oatmeal are broken into 100 orders, for subsequent use sealing up for safekeeping in the material charging feedstock bucket after pulverizing;
(3). it is for subsequent use that the hawthorn processed, kudzu root extract to add in mixer Homogeneous phase mixing 15 minutes, and standard is uniform powder;
(4). it is for subsequent use xylitol to be added in mixer Homogeneous phase mixing 15 minutes, and standard is uniform powder;
(5). it is for subsequent use oligoisomaltose to be added in mixer Homogeneous phase mixing 15 minutes, and standard is uniform powder;
. by the (4) step and the (5) walk mixed material to add in mixer Homogeneous phase mixing 15 minutes for subsequent use, standard is uniform powder;
(7). by powdered phospholipid, vitamin C, Cobastab
1, Cobastab
2, Cobastab
6, that vitamin A to add in mixer Homogeneous phase mixing 15 minutes is for subsequent use, standard is uniform powder;
. (3) walk the, the (6) step and the (7) walk mixed material and add in mixer that to carry out Homogeneous phase mixing 15 minutes for subsequent use, standard is uniform powder;
. by the (8) step and the (2) walk mixed material and add in mixer and carry out multiple Homogeneous phase mixing 15 minutes, standard is uniform powder, and preparation completes.
Usage and dosage of the present invention: get this product 10g, adds warm water 100-150ml, is edible after stirring.
In formula of the present invention:
Semen Tritici aestivi fiber is the natural material extracted from wheat plant, through specific physical technology by its pulverize, is directly be added in varieties of food items as natural raw-food material in European Union and America.Semen Tritici aestivi fiber not only has physical nutritional advantage (such as enrich dietary fiber content, reduce fat, reduce heat etc.), and the advantage that possesses skills (improve quality, control moisture conveying, reduce loss in weight etc.).The content of its dietary fiber reaches more than 98%.It is a kind of outstanding natural dietary fiber raw material.Dietary fiber is that health diet is indispensable, and fiber plays important role in maintenance digestive system health, and absorb enough fibers also can angiocardiopathy preventing, cancer, diabetes and Other diseases simultaneously.Fiber can clean wall of digestive and strengthen digestive function, and fiber simultaneously can dilute and add removing of carcinogen in food and noxious material, the alimentary canal that protection is fragile and preventing colon cancer.
Oat is grass, is referred to as bromegrass, wild oat fruit in Compendium of Material Medica.Oat is not easily peeled, so be called as Avena stivai, is a kind of low sugar, high nutrition, high energy food.Oat nature and flavor are sweet flat.The beneficial spleen of energy nourishes heart, arrest sweating.There is higher nutritive value.Oat is rich in dietary fiber, and can promote enterogastric peristalsis, be beneficial to defecation, heat is low, and glycemic index is low, blood lipid-reducing blood sugar-decreasing.Oat is functional food, has the effect reducing cholesterol, steadily blood sugar.Beta glucan in oat can slow down the increase of Glucose in Blood by Cyclic, prevention and corntrol obesity, diabetes and angiocardiopathy.The dietary fiber that oat is rich in has the effect of cleaning enteron aisle rubbish.
Hawthorn, extract experiment shows to make lecithin in atherosclerosis rabbits blood improve, and cholesterol and the lipid deposition on organ reduces.Enzyme activity is contained into cholesterol and has inhibitory action, the hydroxymethyl glutaryl of its hepatocyte microsome and mucous membrane of small intestine can be made to spread enzyme A reductase vitality and to decline respectively 70% and about 67%.
The root of kudzu vine, contained flavone compound has effect for reducing blood fat, microcirculation can be improved, coronary artery dilator, increase brain and coronary blood flow, reducing heart rate, reduce venous oxygen consumption index and improve the metabolism of ischemic myocardium, also there is antithromboxin, improve the effect of HDL, vasospasm and reduction platelet aggregation.
Powdered phospholipid is a kind of mixed phosphatide, and phosphatide is the basis of human body cell (cell membrane, nuclear membrane, plastid film), has very high nutritive value and medical value.Stress is huge, often with the symptom such as insomnia, impatience, depression, irritability, supplements lecithin, cerebral nerve can be made to obtain nutritional supplementation in time, be beneficial to dispelling fatigue, intensify brain cell, improve the symptom such as irritability, irritability, insomnia caused because of nervous.
Xylitol, be a kind of sweet substance with nutritive value, xylitol sugariness is suitable with sucrose, Absorbable rod amount of heat time water-soluble, be that in all sugar alcohol sweeteners, heat absorption is worth maximum one, therefore when eating in solid form, happy refrigerant sense can be produced in mouth.Xylitol is not cariogenic and have anticariogenic effect.Metabolism does not regulate by insulin, and complete human body metabolism, calorific value is 16.72kJ/g, can be used as the heat energy of diabetes patient.Xylitol adds food as food additives and has enhancing digestive function and cardiac function; Reduce the level of bad cholesterol; Can softening blood vessel, angiosclerotic generation is delayed in the court of a feudal ruler; Reduce blood pressure (maintaining normal blood pressure); Maintain normal blood sugar level; Prevent the generation of cancer cell; Make skin brightening, keep the smooth of skin to moisten; Eliminate heavy metal of body; Alleviate tonicity sense of fatigue, people is easily fallen asleep.
Oligoisomaltose, can have the characteristic promoting that Bifidobacterium significantly breeds.Oligoisomaltose by the stomach of human body and intestinal absorption, but directly can not enter large intestine, is preferentially utilized, help its amount reproduction by Bifidobacterium, is the MF of Bifidobacterium; In intestines, other harmful bacteria then can not utilize, thus can suppress the growth of harmful bacteria, impels the Tiny ecosystem in enteron aisle to adjust to benign cycle.Maintain enteron aisle normal bacteria group balance, especially old and baby.Bifidobacterium can suppress pathogen and spoilage organisms growth, prevents constipation, diarrhea and gastrointestinal disorders.Reduce Blood Cholesterol level, prevent and treat hypertension.Strengthen immune function of human body, prevention antibiotics is to the various adverse side effects of human body.
Vitamin premix (Cobastab
1, vitamin B2, vitamin B6, vitamin A, vitamin C) in:
Cobastab
1, can stimulate circulation, auxiliary hydrochloric acid manufacture, blood flow is formed, carbohydate metabolism. contribute to human perception, and make brain function perform to optimum state; To energetic supersession, growth, appetite, learning ability all plays a part positive. and help human body opposing aging and tobacco and wine to the adverse effect of human body.
Vitamin B2, can promote that red blood cell is formed, antibody manufacture, cellular respiration and grow necessary. relieving eye strain, prevention. and assisted carbohydrate, fat, protein metabolism. when share with A, B2 can maintain and improve the function of respiratory mucosa.
Vitamin B6, be conducive to hydrochloric acid synthesis and fat, the absorption of protein, assist to maintain sodium-potassium balance in health, promote erythrocytic formation. also help in addition and solve the inconvenience that moisture retention brings in body. help the physiological function that brain and immune system are brought into normal play. control cell and increase and the DNA of division, the synthesis of the inhereditary materials such as RNA also be unable to do without B6. in addition B6 can also activate many kinds of enzymes in body. and contribute to the absorption of B12.
The present invention adopts and is applicable to the formula food that high fat of blood and paralytic eat designed by technique scheme, showing, having no side effect through widely applying, patient adheres to eating, can softening blood vessel, improve vascular wall toughness and permeability, thus reach the object that stroke symptom is alleviated in lipopenicillinase.
Detailed description of the invention
This product is raw material based on Semen Tritici aestivi fiber, oat, for the special requirement of high fat of blood and paralytic, be equipped with and multiple there is the nutrients such as batching (hawthorn, the root of kudzu vine) plant extracts of effect for reducing fat, adopt the advanced enzyme that goes out, sterilization technology, finally add xylitol, oligoisomaltose and the vitamin system useful to human body and form.Consisting of of each raw material:
Semen Tritici aestivi fiber 50%-65%, powdered phospholipid 10%-20%, hawthorn 5%-15%, oat 2%-8%, xylitol 2%-8%, oligoisomaltose 2%-8%, the root of kudzu vine 1%-3%, vitamin premix 0.1%-0.5%.
The present invention is applicable to the formula food embodiment 1 that high fat of blood and paralytic eat, and is made up of following raw material:
Semen Tritici aestivi fiber 65%, powdered phospholipid 20%, hawthorn 6.4%, oat 2.5%, xylitol 2.5%, oligoisomaltose 2.5%, the root of kudzu vine 1%, vitamin premix 0.1%.
The present invention is applicable to the formula food embodiment 2 that high fat of blood and paralytic eat, and is made up of following raw material:
Semen Tritici aestivi fiber 57.7%, powdered phospholipid 15%, hawthorn 10%, oat 5%, xylitol 5%, oligoisomaltose 5%, the root of kudzu vine 2%, vitamin premix 0.3%.
The present invention is applicable to the formula food embodiment 3 that high fat of blood and paralytic eat, and is made up of following raw material:
Semen Tritici aestivi fiber 50%, powdered phospholipid 7.5%, hawthorn 15%, oat 8%, xylitol 8%, oligoisomaltose 8%, the root of kudzu vine 3%, vitamin premix 0.5%.
In the various embodiments described above, described vitamin premix is that in every 100g vitamin premix, vitamin C contains 195.5mg, Cobastab
1containing 2mg, Cobastab
2containing 2mg, Cobastab
6containing 2mg, vitamin A is containing 0.5mg, and surplus is maltodextrin.
Preparation method's step of the above embodiment of the present invention is:
(1). hawthorn, the root of kudzu vine are carried out picking picking, picks the impurity picked out in raw material, foreign matter and do not meet the raw material of quality standard; Cleaning raw material water should meet national drinking water standard, and raw material washing should use circulating water, and must not be used for washing other raw materials with the water crossed, different raw materials should not wash together; Dropped in extractor by raw material after cleaning, the purified water adding material quantity 10 times carries out immersion 30 minutes; Soaked raw material decocts 1 hour, temperature 100 DEG C; Open systemic circulation and extract 2 hours, temperature 100 DEG C; Open concentrated again, concentration time is 2 hours, temperature 80 DEG C, and pressure-0.08Mpa, carries out centrifugal spray drying to during relative density 1.1; Dried material answer seal up for safekeeping in charging feedstock bucket for subsequent use;
(2). wheat, oat are carried out picking picking, picks the impurity picked out in raw material, foreign matter and do not meet the raw material of quality standard; Then the buckwheat chosen is put into drying equipment and carry out drying, temperature controls at 110 DEG C, 30 minutes time, proceeds to terminal cooling after dried; Finally, dried wheat, oat are added pulverizer and carry out 100 order pulverizing, and the wheat after pulverizing, oat should keep fineness uniformity; Pulverize after material be respectively charged in Raw material pail seal up for safekeeping for subsequent use;
(3). it is for subsequent use that the hawthorn processed, kudzu root extract to add in mixer Homogeneous phase mixing 15 minutes, and standard is uniform powder;
(4). it is for subsequent use xylitol to be added in mixer Homogeneous phase mixing 15 minutes, and standard is uniform powder;
(5). it is for subsequent use oligoisomaltose to be added in mixer Homogeneous phase mixing 15 minutes, and standard is uniform powder;
. by the (4) step and the (5) walk mixed material to add in mixer Homogeneous phase mixing 15 minutes for subsequent use, standard is uniform powder;
(7). it is for subsequent use powdered phospholipid, vitamin C, vitamin B1, vitamin B2, vitamin B6, vitamin A to be added in mixer Homogeneous phase mixing 15 minutes, and standard is uniform powder;
. (3) walk the, the (6) step and the (7) walk mixed material and add in mixer that to carry out Homogeneous phase mixing 15 minutes for subsequent use, standard is uniform powder;
. by the (8) step and the (2) walk mixed material and add in mixer and carry out multiple Homogeneous phase mixing 15 minutes, standard is uniform powder, and preparation completes.
The present invention is applicable to the formula food that high fat of blood and paralytic eat and is configured by embodiment 2 and tests application clinically.Be 136 routine edible for patients altogether in clinical, wherein man 79 example, female 57 example, 40-50 year 10 examples, 50-60 year 38 examples, 60-70 year 43 examples, more than 70 years old 45 is routine.Patient is high fat of blood and/or paralytic, clinical manifestation mainly lipid deposits caused xanthoma and the artery sclerosis of lipid caused by blood vessel endothelium deposition in corium, in serum, T-CHOL is more than 5.72mmol/L, triglycerides more than 1.70mmol/L, normal with having a dizzy spell, have a headache, uncomfortable in chest, breathe hard, have palpitation, pectoralgia, weak, distortion of commissure, the symptom such as mute, extremity numbness.Patient's three meals in a day take food 60-180 days of the present invention, get this product 10g at every turn, add warm water 100-150ml, are edible after stirring.Show through clinical practice, effective (clinical symptoms, sign are obviously improved, and syndrome integral reduces >=70%) 83 examples, account for 61%, and effectively (clinical symptoms, sign all take a favorable turn. and syndrome integral reduces >=30%) 41 examples, account for 30%, total effective rate reaches 91%.The mental attitude of patient also significantly improves, show by the strengthening of food specific nutrient of the present invention with supplement, can softening blood vessel, improve vascular wall toughness and permeability, thus reach the object that stroke symptom is alleviated in lipopenicillinase.
Claims (6)
1. be applicable to the formula food that high fat of blood and paralytic eat, it is characterized in that being made up of following raw material:
Semen Tritici aestivi fiber 50%-65%, powdered phospholipid 10%-20%, hawthorn 5%-15%, oat 2%-8%, xylitol 2%-8%, oligoisomaltose 2%-8%, the root of kudzu vine 1%-3%, vitamin premix 0.1%-0.5%.
2. the formula food being applicable to high fat of blood and paralytic and eating according to claim 1, is characterized in that being made up of following raw material:
Semen Tritici aestivi fiber 65%, powdered phospholipid 20%, hawthorn 6.4%, oat 2.5%, xylitol 2.5%, oligoisomaltose 2.5%, the root of kudzu vine 1%, vitamin premix 0.1%.
3. the formula food being applicable to high fat of blood and paralytic and eating according to claim 1, is characterized in that being made up of following raw material:
Semen Tritici aestivi fiber 57.7%, powdered phospholipid 15%, hawthorn 10%, oat 5%, xylitol 5%, oligoisomaltose 5%, the root of kudzu vine 2%, vitamin premix 0.3%.
4. the formula food being applicable to high fat of blood and paralytic and eating according to claim 1, is characterized in that being made up of following raw material:
Semen Tritici aestivi fiber 50%, powdered phospholipid 7.5%, hawthorn 15%, oat 8%, xylitol 8%, oligoisomaltose 8%, the root of kudzu vine 3%, vitamin premix 0.5%.
5. according to claim 1,2,3 or 4, be applicable to the formula food that high fat of blood and paralytic eat, it is characterized in that described vitamin premix be in every 100g vitamin premix vitamin C containing 195.5mg, Cobastab
1containing 2mg, Cobastab
2containing 2mg, Cobastab
6containing 2mg, vitamin A is containing 0.5mg, and surplus is maltodextrin.
6. make the method being applicable to the formula food that high fat of blood and paralytic eat according to claim 5, it is characterized in that comprising following preparation method step:
(1). the impurity in hawthorn, the root of kudzu vine, foreign matter and the raw material that do not meet quality standard are carried out picking picking cleaning, the purified water adding material quantity 10 times in raw material after cleaning soaks 30 minutes, soaked raw material decocts 1 hour at the temperature of 100 DEG C, extract 2 hours at 100 DEG C of temperature, again temperature 80 DEG C, concentrate 2 hours under pressure-0.08Mpa, carry out centrifugal spray drying to during relative density 1.1, seal up for safekeeping for subsequent use in dried material charging feedstock bucket;
(2). the impurity in wheat, oat, foreign matter and the raw material that do not meet quality standard are carried out picking picking, then at the temperature of 110 DEG C dry 30 minutes, lower the temperature again after drying, finally, dried wheat, oatmeal are broken into 100 orders, for subsequent use sealing up for safekeeping in the material charging feedstock bucket after pulverizing;
(3). it is for subsequent use that the hawthorn processed, kudzu root extract to add in mixer Homogeneous phase mixing 15 minutes, and standard is uniform powder;
(4). it is for subsequent use xylitol to be added in mixer Homogeneous phase mixing 15 minutes, and standard is uniform powder;
(5). it is for subsequent use oligoisomaltose to be added in mixer Homogeneous phase mixing 15 minutes, and standard is uniform powder;
. by the (4) step and the (5) walk mixed material to add in mixer Homogeneous phase mixing 15 minutes for subsequent use, standard is uniform powder;
(7). by powdered phospholipid, vitamin C, Cobastab
1, Cobastab
2, Cobastab
6, that vitamin A to add in mixer Homogeneous phase mixing 15 minutes is for subsequent use, standard is uniform powder;
. (3) walk the, the (6) step and the (7) walk mixed material and add in mixer that to carry out Homogeneous phase mixing 15 minutes for subsequent use, standard is uniform powder;
. by the (8) step and the (2) walk mixed material and add in mixer and carry out multiple Homogeneous phase mixing 15 minutes, standard is uniform powder, and preparation completes.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510057381.1A CN104664223A (en) | 2015-02-04 | 2015-02-04 | Formula food applicable to eating by patients with high blood fat and stroke and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510057381.1A CN104664223A (en) | 2015-02-04 | 2015-02-04 | Formula food applicable to eating by patients with high blood fat and stroke and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104664223A true CN104664223A (en) | 2015-06-03 |
Family
ID=53300228
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510057381.1A Pending CN104664223A (en) | 2015-02-04 | 2015-02-04 | Formula food applicable to eating by patients with high blood fat and stroke and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104664223A (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1568803A (en) * | 2004-04-30 | 2005-01-26 | 南阳市海达生物技术有限公司 | Food with blood-sugar/blood-fat reducing function and preparation method thereof |
CN1718105A (en) * | 2005-08-09 | 2006-01-11 | 石泽 | Chinese medicinal health-care food for regulating blood-fat and blood-sugar and promoting metabolism |
CN1864535A (en) * | 2006-06-23 | 2006-11-22 | 中国农业大学 | Fat-reducing food of oat series and method for preparing same |
CN101564160A (en) * | 2009-02-25 | 2009-10-28 | 田向东 | Food for preventing and treating hyperlipemia and hyperglycemia and preparation method thereof |
CN103141755A (en) * | 2013-03-28 | 2013-06-12 | 杨健 | Nutritive oatmeal with health care function of reducing blood pressure, blood vat and blood sugar and processing method of nutritive oatmeal |
CN103349052A (en) * | 2013-06-17 | 2013-10-16 | 南阳市新天地生物科技有限公司 | Biscuits suitable for constipated crowd and preparation method thereof |
-
2015
- 2015-02-04 CN CN201510057381.1A patent/CN104664223A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1568803A (en) * | 2004-04-30 | 2005-01-26 | 南阳市海达生物技术有限公司 | Food with blood-sugar/blood-fat reducing function and preparation method thereof |
CN1718105A (en) * | 2005-08-09 | 2006-01-11 | 石泽 | Chinese medicinal health-care food for regulating blood-fat and blood-sugar and promoting metabolism |
CN1864535A (en) * | 2006-06-23 | 2006-11-22 | 中国农业大学 | Fat-reducing food of oat series and method for preparing same |
CN101564160A (en) * | 2009-02-25 | 2009-10-28 | 田向东 | Food for preventing and treating hyperlipemia and hyperglycemia and preparation method thereof |
CN103141755A (en) * | 2013-03-28 | 2013-06-12 | 杨健 | Nutritive oatmeal with health care function of reducing blood pressure, blood vat and blood sugar and processing method of nutritive oatmeal |
CN103349052A (en) * | 2013-06-17 | 2013-10-16 | 南阳市新天地生物科技有限公司 | Biscuits suitable for constipated crowd and preparation method thereof |
Non-Patent Citations (2)
Title |
---|
凌关庭: "《保健食品原料手册(第二版)》", 31 May 2007, 化学工业出版社 * |
母义明等: "《糖尿病》", 30 August 2014, 军事医学科学出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110338402A (en) | A kind of compound probiotic powder and preparation method thereof | |
WO2018145664A1 (en) | Anti-fatigue composition for use in improving endurance performance | |
CN104543834A (en) | Pumpkin powder with blood sugar reducing effect and preparation method thereof | |
CN107752024A (en) | A kind of nutritional meal replacing food for improving the metabolic disturbance diseases such as three height and obesity | |
CN108404019A (en) | Compound chicory root adjusts the solid articles and preparation method thereof of purine metabolic disturbance | |
CN106819854A (en) | A kind of barley young leaf composite powder and preparation method thereof | |
CN101720956B (en) | Banana drink and method for preparing same | |
CN105647773A (en) | Banana-passion fruit compound fruit vinegar and production method thereof | |
CN102177993B (en) | Stomach-strengthening and digestion-promoting tea and preparation method thereof | |
CN102246956A (en) | Healthcare food containing pollen pini and preparation method thereof | |
CN102379391B (en) | Preparation of health food of pine pollen, glucan and natto | |
CN102382751A (en) | Purple sweet potato burdock healthcare vinegar | |
CN106387900A (en) | Composition for regulating blood lipid, blood pressure and blood sugar, as well as application thereof | |
CN101664180A (en) | Health-care nutritional complexing agent with effect of and preparation method thereof | |
CN104106828A (en) | Solid beverage for reducing blood glucose | |
CN105707378A (en) | Black-highland barley coffee with effect of slimming | |
CN102813199A (en) | Health-care food for prevention and adjuvant therapy of cancer, three-high disease and immunity strengthening | |
KR101859166B1 (en) | A composition for removing hangover comprising an herb extract including ginseng | |
EP2842433B1 (en) | Food for nutritional therapy of aids | |
CN108244654A (en) | Caterpillar fungus nutritire breakfast flour | |
CN104017715A (en) | Passion fruit vinegar and preparation method thereof | |
CN107095300A (en) | A kind of biological nutrition compound composition of auxiliary treatment diabetes | |
CN104450470B (en) | A kind of three-bristle cudrania fruit health liquor and preparation method thereof | |
CN104957342A (en) | Low-sugar golden camellia candy | |
CN102166029A (en) | Functional drink of multi-bacterium health-keeping extract of mesona chinensis benth |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150603 |
|
WD01 | Invention patent application deemed withdrawn after publication |